FGF18 Inhibits Clear Cell Renal Cell Carcinoma Proliferation and Invasion via Regulating Epithelial-Mesenchymal Transition
Fibroblast growth factor 18 (FGF18) is a member of the FGF family and contributes to a broad range of biological events. The important role of the overexpression of FGF18 has been identified in the progression of several types of cancers. However, there is still little information on the biological...
Main Authors: | Chen Yang, Zheyu Zhang, Fangdie Ye, Zezhong Mou, Xinan Chen, Yuxi Ou, Chenyang Xu, Siqi Wu, Zhang Cheng, Jimeng Hu, Lujia Zou, Haowen Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01685/full |
Similar Items
-
Blood lipids, lipid-regulatory medications, and risk of bladder cancer: a Mendelian randomization study
by: Zhang Cheng, et al.
Published: (2023-12-01) -
The potential mechanism of Longsheyangquan Decoction on the treatment of bladder cancer: Systemic network pharmacology and molecular docking
by: Zhang Cheng, et al.
Published: (2022-07-01) -
Transcriptomic Analysis of Glycolysis-Related Genes Reveals an Independent Signature of Bladder Carcinoma
by: Zezhong Mou, et al.
Published: (2020-12-01) -
Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour‐specific immunity
by: Zezhong Mou, et al.
Published: (2023-05-01) -
Calculated identification of mutator-derived lncRNA signatures of genomic instability to predict the clinical outcome of muscle-invasive bladder cancer
by: Yingchun Liang, et al.
Published: (2021-09-01)